Anadeo, Liezel .

HRN: 23-84-48  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/06/2023
CEFUROXIME 1.5GM (VIAL)
10/06/2023
10/07/2023
IV
1.5g
Loading Dose
For Repeat CS
Waiting Final Action 
10/06/2023
CEFUROXIME 1.5GM (VIAL)
10/06/2023
10/13/2023
IV
1.5gm
Q8
Repeat CS
Waiting Final Action 
10/07/2023
CEFUROXIME 500MG (TAB)
10/07/2023
10/14/2023
PO
500mg
BID
Repeat CS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: